Published in Respir Res on May 03, 2017
Standardisation of spirometry. Eur Respir J (2005) 48.20
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77
Physical activity in patients with COPD. Eur Respir J (2008) 3.75
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 3.69
Systemic effects of chronic obstructive pulmonary disease. Eur Respir J (2003) 3.44
Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr (2005) 2.74
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
A physical activity questionnaire for the elderly. Med Sci Sports Exerc (1991) 2.39
The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet (2008) 2.35
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 2.29
Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J (2002) 2.07
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J (2014) 2.01
Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res (2010) 1.93
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. Blood (2011) 1.88
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax (1991) 1.79
Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax (2005) 1.78
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Large potentials of small heat shock proteins. Physiol Rev (2011) 1.61
Simultaneous visualization of multiple antigens with tyramide signal amplification using antibodies from the same species. J Histochem Cytochem (2007) 1.54
siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab (2006) 1.48
Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling. Nat Protoc (2006) 1.40
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med (2000) 1.24
Systemic effects in COPD. Chest (2002) 1.19
Skeletal muscle satellite cells: background and methods for isolation and analysis in a primary culture system. Methods Mol Biol (2012) 1.16
NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax (2004) 1.14
ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L. Stem Cells (2009) 1.11
Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2003) 1.10
Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation. J Biol Chem (2011) 1.04
Sarcopenia: origins and clinical relevance. Clin Geriatr Med (2011) 1.04
The decrease of the cytoskeleton tubulin follows the decrease of the associating molecular chaperone alphaB-crystallin in unloaded soleus muscle atrophy without stretch. FASEB J (2005) 0.98
The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle. Cell Cycle (2014) 0.97
Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve (2002) 0.96
Evidence that the histone methyltransferase Dot1 mediates global genomic repair by methylating histone H3 on lysine 79. J Biol Chem (2011) 0.95
Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle. Int J Mol Med (2012) 0.94
Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehabil (2009) 0.92
Satellite cells senescence in limb muscle of severe patients with COPD. PLoS One (2012) 0.92
Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J (2005) 0.90
2-D DIGE analysis of the mitochondrial proteome from human skeletal muscle reveals time course-dependent remodelling in response to 14 consecutive days of endurance exercise training. Proteomics (2011) 0.90
Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol (2011) 0.87
The relation of fat-free mass to maximum exercise performance in patients with chronic obstructive pulmonary disease. Lung (2000) 0.87
Structural alterations of skeletal muscle in copd. Front Physiol (2014) 0.85
RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells. Biochem Biophys Res Commun (2003) 0.84
Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 0.81
Skeletal muscle tissue from the Goto-Kakizaki rat model of type-2 diabetes exhibits increased levels of the small heat shock protein Hsp27. Mol Med Rep (2011) 0.80
STOP accelerating lung aging for the treatment of COPD. Exp Gerontol (2014) 0.80
The many faces of histone H3K79 methylation. Mutat Res Rev Mutat Res (2016) 0.79
Senescence-like changes induced by expression of p21(waf1/Cip1) in NIH3T3 cell line. Cell Res (2002) 0.78
State of the art of 2D DIGE. Proteomics Clin Appl (2015) 0.77
Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls. Respir Res (2015) 0.76